Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.65M Buy
144,311
+84,674
+142% +$1.81M 0.05% 539
2026
Q1
$1.21M Sell
59,637
-22,509
-27% -$501K 0.02% 946
2025
Q4
$1.57M Buy
+82,146
New +$1.73M 0.04% 738
2025
Q2
Sell
-80,583
Closed -$1.04M 1600
2025
Q1
$1.04M Buy
+80,583
New +$1.3M 0.07% 394
2024
Q3
Sell
-35,562
Closed -$879K 1250
2024
Q2
$879K Buy
35,562
+28,135
+379% +$799K 0.05% 550
2024
Q1
$244K Sell
7,427
-334
-4% -$11.4K 0.02% 1061
2023
Q4
$282K Buy
+7,761
New +$266K 0.03% 852
2023
Q3
Sell
-12,997
Closed -$498K 1009
2023
Q2
$498K Buy
+12,997
New +$480K 0.05% 566

Other funds holding ADNT

Y-Intercept (HK)'s ADNT Position: Q2 2026 in Review

Y-Intercept (HK) increased its Adient (ADNT) stake by 142% in Q2 2026, buying an estimated $1.81M and bringing the position to 144,311 shares worth $2.65M. The position accounts for 0.05% of the portfolio, ranked #539.

Y-Intercept (HK) first reported a position in ADNT in Q2 2023 and has held it in 8 quarters since. 63 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • Y-Intercept (HK) held 144,311 shares of Adient worth $2.65M as of Q2 2026.
  • Y-Intercept (HK) bought 84,674 Adient shares in Q2 2026, an estimated $1.81M.
  • Adient made up 0.05% of Y-Intercept (HK)'s portfolio in Q2 2026, its #539 holding.
  • Y-Intercept (HK) first reported a position in Adient in Q2 2023 and has held it in 8 quarters since.
  • 63 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.